Synopsis
We
established a practical protocol for quantitatively imaging the cerebral
metabolic rates of ATP production via ATPase and creatine kinase (CK) reactions
in human brain at 7T using three dimensional (3D) chemical shift imaging (CSI)
and in vivo 31P MR
spectroscopy (MRS) in combine with magnetization transfer (MT) approach.
Subsequently, we applied this 3D 31P-MT imaging protocol to quantify
the regional phosphorous metabolites concentrations, ATPase and CK reaction
rate constants and fluxes and the intracellular pH in human brain at rest and
during visual stimulation. The results
of this study provide the values of key parameters relevant to ATP metabolism
in absolute scale, which allow quantitative evaluation of regional cerebral
energetics in resting human brain and its functional changes.PURPOSE
To
establish an imaging protocol for quantifying phosphorous metabolites and ATP production
rates in human brain at 7T; and to determine regional ATP metabolic rates and
functional neuroenergetic changes in healthy human.
INTRODUCTION
Cerebral energy metabolism of ATP
provides chemical energy for neuronal activities and brain functions. In vivo
31P MRS with
magnetization transfer (MT) is the only method capable of directly and
non-invasively assessing the cerebral metabolic rate of ATP production (CMR
ATP)
via ATPase and creatine kinase (CK) reactions
1-4. However, the applicability
of this technique for quantifying regional CMR
ATP has not been fully
demonstrated in human brain. We report here a study protocol for imaging key
phosphorous metabolites and ATP metabolic rates in human brain at 7T. It has
been applied to determine energetic parameters in resting and stimulated brain and
to evaluate their regional changes in response to visual stimulation.
METHODS
Healthy
young subjects were
recruited. All measurements were conducted at 7Tesla/90cm Siemens scanner
using a
1H/
31P surface coil probe placed over the occipital
lobe. A small phosphorus reference sphere was fixed at center of the
31P
coil for power calibration. T
1-weighted anatomic image, fMRI data (stimulation paradigm:
8Hz flashing checkerboard with a central fixation point) and 3D-CSI (FOV=12×12×9cm,
matrix=7×7×5, TR=1.2s, total NT=896 and flip angle (FA)=48°) with and without γ-ATP
saturation
5 at resting and stimulated conditions were acquired. After
each human scan, 3D
31P-CSI data was obtained on an ATP phantom ([ATP]=10mM)
with identical imaging resolution, coil loading and sample position. The
experimental setup is shown in Fig. 1. The
31P RF B
1
field and FA map were also obtained.
The fMRI
and the
31P-CSI data were analyzed with SPM and jMRUI software, respectively. The AMARES
algorithm
6 was used in spectra fitting; the integrals of phosphorous
metabolites were corrected for the saturation effects based on relevant T
1
and FA information. The ATP content of each subject was determined by comparing
the brain signals in selected brain region to that of ATP phantom (see Fig.1); which
was then used as an internal standard for determining the concentration of other
phosphorous metabolites including PCr and Pi. The forward reaction rate
constant of ATPase (k
f_ATP)
and CK (k
f_CK) were determined
according to: M
c/M
s ≈1+k
f×T
1nom
where M
c and M
s are control and g-ATP saturated magnetization
and T
1nom is the nominal T
1 for Pi or PCr
7.
The metabolic rate of ATP production via ATPase (Flux_ATP) or CK (Flux_CK)
reactions were determined by multiplying the k
f with [Pi] or [PCr], respectively.
RESULTS
Fig.
2 and 3 display typical
31P-MT spectra and fMRI maps of the human brain
obtained in this study, showing excellent spectral quality and robust
functional activation. The results of the neuroenergetic measurement in
multiple subjects/ROIs are summarized in Table 1. The brain ATP levels in resting human brain were
similar with [ATP] = 2.96 ± 0.03 mM between all measurements. The regional
reaction rate constants and fluxes within the primary visual cortex are similar
to previous literature reports
1-4,8. We observed stimulation induced
increases of [Pi] (10±8%) and ATPase reaction rate constant (24±11%) and flux
(37±8%); a small reduction of [PCr] (-0.5%) and moderate increases (~5%) of CK
reaction rate constant and flux were detected in activated brain region.
However, including surrounding CSI voxels into the ROIs led to substantially less
functional changes in [Pi] and ATPase reaction rate and flux, which were similar
to our previous dynamic functional study without using the 3D-CSI approach
8.
Interestingly, a higher intracellular pH in activated brain region during visual
stimulation was reliably detected in all subjects at 7T, despite the fact of
elevated cellular lactate in the visual cortex
9, suggesting a
potential role of pH in brain function and activation.
DISCUSSION
and CONCLUSION
We
established a quantitatively imaging protocol for key phosphorous metabolites
and ATP production rates in human brain. The energetic parameters were determined
and reported in absolute scale, which is essential for investigating the baseline
brain energetics under various pathophysiological conditions. The functional
study performed in this work provides a good example that demonstrated the applicability
of the 3D
31P-MT imaging technique for evaluating regional energetic
changes evoked by functional stimulation. A significant amount of ATP energy
consumed during visual stimulation in supporting evoked neuronal activity in
the human visual cortex. A 37% increase of ATPase flux detected during visual
stimulation presents an increment of ATP expenditure (~1.7 billion more ATPs/s/neuron) from
the resting state
10. The methodology described herein should provide
a practical tool that can be applied in various studies for understanding the
neuroenergetics in human health and diseases.
Acknowledgements
NIH grants of R24 MH106049, R01
NS070839,
S10 RR029672, P41
EB015894 and P30 NS076408; and Keck Foundation.References
[1]
Lei et al., PNAS; 100:14409-14414
(2003); [2] Du et al., PNAS; 105:6409-6414 (2008); [3] Du et al.,
MRM; 57:103-14 (2007); [4] Chen et al., MRM; 38:551-7 (1997);
[5] de Graaf et al., NMR Biomed; 9:185-194 (1996); [6] Vanhamme et
al, JMR; 129:35-43 (1997); [7] Xiong et
al., Circ. Res; 108: 653-663 (2011); [8] Lee et
al., Proc. ISMRM; 22:12 (2014); [9] Prichard et al., PNAS; 88:5829-5831
(1991); [10] Zhu et al., NeuroImage; 20: 2017-2027 (2012).